Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07449793) titled 'Biochemical Response and Clinical Outcomes in Patients With PBC' on Feb. 26.

Study Type: Observational

Primary Sponsor: RenJi Hospital

Condition: Primary Biliary Cholangitis (PBC) Primary Biliary Cholangitis

Intervention: Other: Only observation

Recruitment Status: Recruiting

Date of First Enrollment: February 1, 2026

Target Sample Size: 3000

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07449793

Published by HT Digital Content Services with permission from Health Daily Digest....